Recent Comments

Comment RSS

Viagra (Sildenafil citrate) News and Research RSS Feed - Viagra (Sildenafil citrate) News and Research

Sildenafil citrate, sold as Viagra, Revatio and under various other trade names, is a drug used to treat erectile dysfunction and pulmonary arterial hypertension (PAH). It was developed and is being marketed by the pharmaceutical company Pfizer. It acts by inhibiting cGMP specific phosphodiesterase type 5, an enzyme that regulates blood flow in the penis. Since becoming available in 1998, sildenafil has been the prime treatment for erectile dysfunction; its primary competitors on the market are tadalafil (Cialis) and vardenafil (Levitra). It is frequently called the 'blue pill'.

Study of pulmonary hypertension treatment in sickle cell patients stopped by NHLBI

28. July 2009 16:02
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial testing a drug treatment for pulmonary hypertension in adults with sickle cell disease nearly one year early due to safety concerns. [More]

Scientists investigate health benefits of molecule associated with male sexual arousal

24. June 2009 20:30
Medical scientists at the University of Leicester are investigating how signalling molecules known to control blood pressure and penile erection act to regulate brain function and which have potential for treatments of migraine, chronic pain, epilepsy and Alzheimer's disease. [More]

New perspective on the causes, effects and potential treatment of sexual dysfunction

23. June 2009 05:25
Couples' treatment for sexual problems and other innovative approaches to improving sexual health for men and women are on the agenda of sexual medicine experts. [More]

Research looks for best treatment for erectile dysfunction

18. May 2009 16:58
A new report issued today by HHS' Agency for Healthcare Research and Quality found that there isn't enough evidence to determine which drugs work best to treat erectile dysfunction and which cause the least harm. Erectile dysfunction is a common sexual disorder that prevents men from getting or keeping an erection. It affects between 15 million and 30 million men in the United States. [More]

Pfizer to give away 70 of its most widely prescribed drugs to those who lost jobs

15. May 2009 18:31
Pfizer on Thursday announced a new program that would provide some of its existing customers access to more than 70 types of medications at no cost if they have recently been laid off or lost their prescription drug coverage, USA Today reports. The program -- called MAINTAIN, or Medicines Assistance for Those who Are in Need -- will begin July 1. [More]

Posted in: Pharmaceutical News

Tags: , , , , ,

Viagra, Levitra and Cialis may deserve a second look in women with sexual dysfunction

20. April 2009 08:44
New studies indicate the three drugs used to treat male impotence also appear to work in females, albeit a little differently, and should give the scientific community pause to take a second look at their potential in the 40 percent of women who report sexual dysfunction, researchers say. [More]

Tadalafil and sildenafil for ED do not appear to damage vision over 6 months

13. April 2009 21:17
Two medications used to treat erectile dysfunction in men (tadalafil and sildenafil) do not appear to have visual side effects when taken daily for six months, despite concerns about eye-related complications, according to a report in the April issue of Archives of Ophthalmology , one of the JAMA/Archives journals. [More]

Fake internet drugs could be funding terrorism

29. January 2009 08:34
People who buy fake internet drugs could be risking their lives and supporting terrorism, according to an editorial in the February issue of IJCP, the International Journal of Clinical Practice. [More]

Posted in: Pharmaceutical News

Tags: , , , , ,

Protein that regulates hormones critical to women's health found in pituitary

12. January 2009 22:08
University of Wisconsin-Madison researchers have solved the mystery surrounding a "rogue protein" that plays a role in the release of neurotransmitters and hormones in the brain. [More]

Viagra may help protect heart from high blood pressure damage

5. January 2009 22:22
Johns Hopkins and other researchers report what is believed to be the first direct evidence in lab animals that the erectile dysfunction drug sildenafil amplifies the effects of a heart-protective protein. [More]

Scientists map steps to block enzyme phosphodiesterase 5's action in heart failure

12. November 2008 00:13
Taking a cue from the way drugs like Viagra put the biological brakes on a key enzyme involved in heart failure, scientists at Johns Hopkins have mapped out a key chemical step involved in blocking the enzyme. [More]

Exercise-induced fatigue in muscular dystrophies, study points to potential new therapies

26. October 2008 23:03
A University of Iowa study suggests that the prolonged fatigue after mild exercise that occurs in people with many forms of muscular dystrophy is distinct from the inherent muscle weakness caused by the disease. [More]

New Zealand issues warning on 'dodgy' treatments for erectile dysfunction

8. August 2008 03:08
New Zealand's Director-General of Health, Stephen McKernan, is warning people about the potential health dangers associated with three products promoted and sold in New Zealand for sexual enhancement or the treatment of erectile dysfunction which may contain an undeclared therapeutic substance. [More]

Posted in: Men's Health News

Tags: , ,

Viagra and Levitra ED drugs shown to allow more chemo to reach brain tumors

28. July 2008 19:49
In a study using laboratory animals, researchers found that medications commonly prescribed for erectile dysfunction opened a mechanism called the blood-brain tumor barrier and increased delivery of cancer-fighting drugs to malignant brain tumors. [More]

U.S. authorities seize Xiadafil VIP tablets after company refuses to recall product

24. July 2008 19:59
At the request of the U.S. Food and Drug Administration, U.S. Marshals seized nearly $74,000 worth of Xiadafil VIP tablets, Lots 6K029 and 6K209-SEI, distributed by SEI Pharmaceuticals, Inc. of Miami, Fla. Although marketed as a dietary supplement to treat erectile dysfunction (ED) and for sexual enhancement, these lots represent an illegally marketed drug containing an undeclared ingredient. [More]
News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.